Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neuron Biopharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11498
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatment of Alzheimer’s disease. NBP’s pharmaceutical products include NST0037, NST0076, NST0078, and NPS0158/163. The company develops research projects for public institutions, biotechnological, pharmaceutical, agro-food and animal health area, among others. It conducts research on the implications of the regulation of cholesterol in the brain. The company operates through universities and pharmaceutical companies. It also operates in the US through its subsidiary. NBP is headquartered in Granada, Spain.

Neuron Biopharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Neuron Bio and CIEN Foundation Enter into Agreement 11
Equity Offering 12
Neuron Bio Raises USD3.4 Million in Rights Offering of Shares 12
Neuron Bio Raises USD1 Million in Rights Offering of Shares 13
Neuron Bio to Raise USD2 Million in Private Placement of Shares 14
Neuron Biopharma SA – Key Competitors 15
Neuron Biopharma SA – Key Employees 16
Neuron Biopharma SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neuron Bio and CIEN Foundation Enter into Agreement 11
Neuron Bio Raises USD3.4 Million in Rights Offering of Shares 12
Neuron Bio Raises USD1 Million in Rights Offering of Shares 13
Neuron Bio to Raise USD2 Million in Private Placement of Shares 14
Neuron Biopharma SA, Key Competitors 15
Neuron Biopharma SA, Key Employees 16
Neuron Biopharma SA, Other Locations 17

List of Figures
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biocodex-製薬・医療分野:企業M&A・提携分析
    Summary Biocodex (Biocodex) is a drug manufacturing company that develops and commercializes drugs. The company offers products for gastro enteric diseases, pain management, neurological and psychiatric conditions, rheumatic pains, and ENT conditions. Its products include Saccharomyces boulardii, an …
  • PHOENIX Group:企業の戦略・SWOT・財務分析
    PHOENIX Group - Strategy, SWOT and Corporate Finance Report Summary PHOENIX Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MEDITE Cancer Diagnostics Inc (MDIT)-医療機器分野:企業M&A・提携分析
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • GeoVax Labs Inc (GOVX)-製薬・医療分野:企業M&A・提携分析
    Summary GeoVax Labs Inc (GeoVax) is a clinical-stage biotechnology company, which develops human vaccines for diseases caused by HIV, cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus o …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ID Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy and other bio products. It provides vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s v …
  • Boehringer Ingelheim GmbH:企業の戦略的SWOT分析
    Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kawasumi Laboratories Inc (7703):企業の財務・戦略的SWOT分析
    Summary Kawasumi Laboratories Inc (Kawasumi) is a medical device company that manufactures and distributes disposable blood collection and transfusion sets. The company’s product portfolio includes hemodialysis, plasmapheresis, blood banking and transfusion, infusion therapy, andendovascular repair …
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, photography, creative and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • The Stars Group Inc (TSGI):企業の財務・戦略的SWOT分析
    The Stars Group Inc (TSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • VIA Technologies Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • TransGenic Inc (2342):企業の財務・戦略的SWOT分析
    TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a drug discovery company that develops medicines to treat cancer and neurological diseases. The company uses sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. …
  • Charles River Laboratories International, Inc.:戦略・SWOT・企業財務分析
    Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Arsanis Inc (ASNS):製薬・医療:M&Aディール及び事業提携情報
    Summary Arsanis Inc (Arsanis) is a clinical-stage biopharmaceutical company that focuses on the development of monoclonal antibody immunotherapies for the treatment of critical infectious diseases. The company’s pipeline product portfolio includes ASN100, for staphylococcus aureus; ASN500, targets r …
  • Stanley Black & Decker Inc:戦略・SWOT・企業財務分析
    Stanley Black & Decker Inc - Strategy, SWOT and Corporate Finance Report Summary Stanley Black & Decker Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Abraxas Petroleum Corp (Abraxas) is an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mi …
  • Xenon Pharmaceuticals Inc (XENE):企業の財務・戦略的SWOT分析
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • Rebiotix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that offers treatment solutions for debilitating diseases by harnessing the power of the human microbiome. The company harnesses microbiota restoration therapy, a drug delivery platform that releases hea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆